NCT05994703View on ClinicalTrials.gov

Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Smoking CessationHarm Reduction
Interventions
DRUG

d-cycloserine

d-cycloserine (DCS) 100 mg taken orally, once a day for six weeks.

OTHER

Juul e-cigarette

Juul use as often as the participant likes for 12 weeks.

Trial Locations (2)

27617

Rose Research Center, Raleigh

28262

Rose Research Center, Charlotte

All Listed Sponsors
collaborator

Foundation for a Smoke Free World INC

OTHER

lead

Rose Research Center, LLC

INDUSTRY